Skip to content

A study on the effect of rare sugar syrup on blood glucose level : randomized, placebo-controlled, double blind cross-over trial

A study on the effect of rare sugar syrup on blood glucose level : randomized, placebo-controlled, double blind cross-over trial - A study on the effect of rare sugar syrup on blood glucose level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018120
Enrollment
50
Registered
2016-07-30
Start date
2015-06-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult and borderline

Interventions

Intake of rare sugar syrup dissolved in coffee. Intake of granulated sugar dissolved in coffee.

Sponsors

CPCC Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females aged 20 to 64 years old (2) Subjects who possible to take a blood sample repeatedly with the passage of time (3) Subjects who show the comparatively large increasing value of blood glucose in the participants, after the glucose load test in the preliminary check. (4) Subjects who can make self-judgment and are voluntarily giving written informed consent.

Exclusion criteria

Exclusion criteria: (1)These prescreened medicine. (2)These having Food for Specified Health Uses (FOSHU) and/or health food. (3)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., diabetes, circulatory organ, liver, kidney, heart and/or digestive organ). (4)Pregnant women, lactating women, or women who want to get pregnant during the trial period (5)Heavy alcohol drinker. (6)Those that have extremely disheveled lifestyle and/or dietary habits. (7)Subjects who have previous medical history of drug and/or food allergy. (8)Subjects who have donated over 200 mL of blood and/or blood components within the last one month prior to the current study. (9)Subjects who have donated over 400 mL of blood and/or blood components within the last tree months prior to the current study. (10)Subjects who have donated over 400 mL of blood and/or blood components within the last four months prior to the current study. (11)Subjects who collected blood amount of blood sampling over 1200 mL within the last twelve months prior to the current study and this clinical trial's blood sampling. (12)Subjects who collected blood amount of blood sampling over 800 mL within the last twelve months prior to the current study and this clinical trial's blood sampling. (13)Subjects who have donated over 400 mL of blood and/or blood components within the last four months prior to the current study. (14)Subjects who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
AUC of blood glucose and insulin after the test beverage load

Secondary

MeasureTime frame
Blood glucose and insulin levels in each time points after the test beverage load

Countries

Japan

Contacts

Public ContactKazuyoshi shibata

CPCC Co.,Ltd. Plan Sales Department

cpcc-contact@cpcc.co.jp03-5297-3112

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026